The largest database of trusted experimental protocols

Example 16 t1165.85.2.1 cells

Manufactured by R&D Systems

The Example 16 T1165.85.2.1 cells are a type of mammalian cell line. They are derived from a specific tissue source and have been characterized for certain properties. The cells can be used for various research applications in a laboratory setting.

Automatically generated - may contain errors

2 protocols using example 16 t1165.85.2.1 cells

1

Antagonism of Murine Plasmacytoma Cells by IL-6 Fab Mutants

Check if the same lab product or an alternative is used in the 5 most similar protocols

Example 16

T1165.85.2.1 cells (R&D Systems) are a murine plasmacytoma cell line that proliferates in response to mouse, rat, or human IL-6. To measure antagonism from the EBI-029 Fab mutants, 25 μL of 2 ng/mL human IL-6 (R&D Systems 206-IL-010/CF) was mixed with 25 μL of each Fab variant at a range of concentrations in a 96 well plate and incubated at RT for 30 minutes. T1165 cells in log phase were pelleted and resuspended in assay media (90% RPMI 1640, 10% FBS, 2 mM L-glutamine, Pen-Strep) at 2×105 cells/mL. 50 L of cell suspension was added to each well of IL-6/Fab mixtures to bring the final IL-6 concentration to 0.5 ng/mL. The cells were incubated at 37° C./5% C02 for 72 hours. 100 μL of Cell-Titer Glo® reagent (Promega) was added to each well and incubated at RT for 10 minutes. Luminescence was measured on a SpectraMax M5 plate reader. All mutants showed significantly greater potency compared to the wt EBI-029 Fab with no measurable IL-6 signaling over the range of Fab concentrations tested (see FIG. 7).

+ Open protocol
+ Expand
2

Antagonism of Murine Plasmacytoma Cells by IL-6 Fab Mutants

Check if the same lab product or an alternative is used in the 5 most similar protocols

Example 16

T1165.85.2.1 cells (R&D Systems) are a murine plasmacytoma cell line that proliferates in response to mouse, rat, or human IL-6. To measure antagonism from the EBI-029 Fab mutants, 25 μL of 2 ng/mL human IL-6 (R&D Systems 206-IL-010/CF) was mixed with 25 μL of each Fab variant at a range of concentrations in a 96 well plate and incubated at RT for 30 minutes. T1165 cells in log phase were pelleted and resuspended in assay media (90% RPMI 1640, 10% FBS, 2 mM L-glutamine, Pen-Strep) at 2×105 cells/mL. 50 L of cell suspension was added to each well of IL-6/Fab mixtures to bring the final IL-6 concentration to 0.5 ng/mL. The cells were incubated at 37° C./5% C02 for 72 hours. 100 μL of Cell-Titer Glo® reagent (Promega) was added to each well and incubated at RT for 10 minutes. Luminescence was measured on a SpectraMax M5 plate reader. All mutants showed significantly greater potency compared to the wt EBI-029 Fab with no measurable IL-6 signaling over the range of Fab concentrations tested (see FIG. 7).

+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!